New Market Research Report: Lebanon Pharmaceuticals & Healthcare Report Q2 2014
Lebanon's pharmaceutical market benefits from high drug prices where branded generic drugs account for a large portion of the market. The country's high per capita spending on pharmaceuticals, along with increased efforts in providing investment incentives are key factors in driving market growth. However, the ongoing civil war in Syria shows no signs of abating and is continuing to cause both political and economic strain within Lebanon, negatively impacting our projections in Q214
View full press release